Improved diagnosis of gestational parvovirus B19 infection at the time of nonimmune fetal hydrops

Journal of Infectious Diseases

Volumn 197, Issue 1, 2008, Pages 58-62

  Enders, Martin ^a   Weidner, Andrea ^a   Rosenthal, Tessa ^a   Baisch, Carola ^a   Hedman, Lea ^b   Söderlund Venermo, Maria ^b   Hedman, Klaus ^b  

^a Labor Enders und Partner   (Germany)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

DNA; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ADULT; ARTICLE; BLOOD SAMPLING; ENZYME IMMUNOASSAY; EPITOPE TYPE SPECIFICITY; ERYTHEMA INFECTIOSUM; FEMALE; FETUS HYDROPS; GENOME; GESTATION PERIOD; HUMAN; INFANT; MAJOR CLINICAL STUDY; PARVOVIRUS; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; VIRUS IMMUNITY; VIRUS LOAD;

ANTIBODIES, VIRAL; ANTIBODY AFFINITY; FEMALE; HUMANS; HYDROPS FETALIS; IMMUNOENZYME TECHNIQUES; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PARVOVIRIDAE INFECTIONS; PARVOVIRUS B19, HUMAN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; SENSITIVITY AND SPECIFICITY; ULTRASONOGRAPHY, PRENATAL; VIREMIA;

EID: 39349093834     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/524302     Document Type: Article

References (40)

1. Anderson MJ, Jones SE, Fisher-Hoch SP, et al. Human parvovirus, the cause of erythema infectiosum (fifth disease)? Lancet 1983; 1:1378.
2. Harger JH, Adler SP, Koch WC, Harger GF. Prospective evaluation of 618 pregnant women exposed to parvovirus B19: risks and symptoms. Obstet Gynecol 1998; 91:413-20.
3. Kelly HA, Rae PB, Donnelly JK, Leydon JA. Fifth disease in a small rural community: what are the consequences? Aust Fam Physician 1999; 28:139-44.
4. Valeur-Jensen AK, Pedersen CB, Westergaard T, et al. Risk factors for parvovirus B19 infection in pregnancy. JAMA 1999; 281:1099-105.
5. Enders M, Weidner A, Enders G. Current epidemiological aspects of human parvovirus B19 infection during pregnancy and childhood in the western part of Germany. Epidemiol Infect 2007; 135:563-9.
6. Brown T, Anand A, Ritchie LD, Clewley JP, Reid TM. Intrauterine parvovirus infection associated with hydrops fetalis. Lancet 1984; 2:1033-4.
7. Prospective study of human parvovirus (B19) infection in pregnancy. Public Health Laboratory Service Working Party on Fifth Disease. BMJ 1990; 300:1166-70.
8. Miller E, Fairley CK, Cohen BJ, Seng C. Immediate and long term outcome of human parvovirus B19 infection in pregnancy. Br J Obstet Gynaecol 1998; 105:174-8.
9. Yaegashi N, Niinuma T, Chisaka H, et al. Serologic study of human parvovirus B19 infection in pregnancy in Japan. J Infect 1999; 38:30-5.
10. Nunoue T, Kusuhara K, Hara T. Human fetal infection with parvovirus B19: maternal infection time in gestation, viral persistence and fetal prognosis. Pediatr Infect Dis J 2002; 21:1133-6.
11. Enders M, Weidner A, Zoellner I, Searle K, Enders G. Fetal morbidity and mortality after acute human parvovirus B19 infection in pregnancy: prospective evaluation of 1018 cases. Prenat Diagn 2004; 24:513-8.
12. Chisaka H, Ito K, Niikura H, et al. Clinical manifestations and outcomes of parvovirus B19 infection during pregnancy in Japan. Tohoku J Exp Med 2006; 209:277-83.
13. Rodis JF, Quinn DL, Gary GW Jr, et al. Management and outcomes of pregnancies complicated by human B19 parvovirus infection: a prospective study. Am J Obstet Gynecol 1990; 163:1168-71.
14. Crane J. Parvovirus B19 infection in pregnancy. J Obstet Gynaecol Can 2002; 24:727-43.
15. Morgan-Capner P, Crowcroft NS. Guidelines on the management of, and exposure to, rash illness in pregnancy (including consideration of relevant antibody screening programmes in pregnancy). Commun Dis Public Health 2002; 5:59-71.
16. de Jong EP, de Haan TR, Kroes AC, Beersma MF, Oepkes D, Walther FJ. Parvovirus B19 infection in pregnancy. J Clin Virol 2006; 36:1-7.
17. Doyle S, Kerr S, O'Keeffe G, O'Carroll D, Daly P, Kilty C. Detection of parvovirus B19 IgM by antibody capture enzyme immunoassay: receiver operating characteristic analysis. J Virol Methods 2000; 90:143-52.
18. Beersma MF, Claas EC, Sopaheluakan T, Kroes AC. Parvovirus B19 viral loads in relation to VP1 and VP2 antibody responses in diagnostic blood samples. J Clin Virol 2005; 34:71-5.
19. Söderlund M, Brown CS, Cohen BJ, Hedman K. Accurate serodiagnosis of B19 parvovirus infections by measurement of IgG avidity. J Infect Dis 1995; 171:710-3.
20. Kaikkonen L, Lankinen H, Harjunpää I, et al. Acute-phase-specific heptapeptide epitope for diagnosis of parvovirus B19 infection. J Clin Microbiol 1999; 37:3952-6.
21. Kaikkonen L, Söderlund-Venermo M, Brunstein J, et al. Diagnosis of human parvovirus B19 infections by detection of epitope-type-specific VP2 IgG. J Med Virol 2001; 64:360-5.
22. Enders M, Schalasta G, Baisch C, et al. Human parvovirus B19 infection during pregnancy - value of modern molecular and serological diagnostics. J Clin Virol 2006; 35:400-6.
23. Searle K, Guilliard C, Wallat S, Schalasta G, Enders G. Acute parvovirus B19 infection in pregnant women - an analysis of serial samples by serological and semi-quantitative PCR techniques. Infection 1998; 26:139-43.
24. Schalasta G, Schmid M, Lachmund T, Enders G. Light Cycler consensus PCR for rapid and differential detection of human erythrovirus B19 and V9 isolates. J Med Virol 2004; 73:54-9.
25. Searle K, Guilliard C, Enders G. Parvovirus B19 diagnosis in pregnant women - quantification of IgG antibody levels (IU/ml) with reference to the international parvovirus B19 standard serum. Infection 1997; 25:32-4.
26. Söderlund M, Brown KE, Meurman O, Hedman K. Prokaryotic expression of a VP1 polypeptide antigen for diagnosis by a human parvovirus B19 antibody enzyme immunoassay. J Clin Microbiol 1992; 30:305-11.
27. Korhonen MH, Brunstein J, Haario H, Katnikov A, Rescaldani R, Hedman K. A new method with general diagnostic utility for the calculation of immunoglobulin G avidity. Clin Diagn Lab Immunol 1999; 6:725-8.
28. Servant A, Laperche S, Lallemand F, et al. Genetic diversity within human erythroviruses: identification of three genotypes. J Virol 2002; 76:9124-34.
29. Hokynar K, Norja P, Laitinen H, et al. Detection and differentiation of human parvovirus variants by commercial quantitative real-time PCR tests. J Clin Microbiol 2004; 42:2013-9.
30. Wattre P, Dewilde A, Subtil D, Andreoletti L, Thirion V. A clinical and epidemiological study of human parvovirus B19 infection in fetal hydrops using PCR Southern blot hybridization and chemiluminescence detection. J Med Virol 1998; 54:140-4.
31. Zerbini M, Musiani M, Gentilomi G, Venturoli S, Gallinella G, Morandi R. Comparative evaluation of virological and serological methods in prenatal diagnosis of parvovirus B19 fetal hydrops. J Clin Microbiol 1996; 34:603-8.
32. Dieck D, Schild RL, Hansmann M, Eis-Hübinger AM. Prenatal diagnosis of congenital parvovirus B19 infection: value of serological and PCR techniques in maternal and fetal serum. Prenat Diagn 1999; 19:1119-23.
33. Török TJ, Wang QY, Gary GW Jr, Yang CF, Finch TM, Anderson LJ. Prenatal diagnosis of intrauterine infection with parvovirus B19 by the polymerase chain reaction technique. Clin Infect Dis 1992; 14:149-55.
34. Knöll A, Louwen F, Kochanowski B, et al. Parvovirus B19 infection in pregnancy: quantitative viral DNA analysis using a kinetic fluorescence detection system (TaqMan PCR). J Med Virol 2002; 67:259-66.
35. de Haan TR, Beersma MF, Oepkes D, de Jong EP, Kroes AC, Walther FJ. Parvovirus B19 infection in pregnancy: maternal and fetal viral load measurements related to clinical parameters. Prenat Diagn 2007; 27:46-50.
36. Musiani M, Zerbini M, Gentilomi G, Plazzi M, Gallinella G, Venturoli S. Parvovirus B19 clearance from peripheral blood after acute infection. J Infect Dis 1995; 172:1360-3.
37. Lefrère JJ, Servant-Delmas A, Candotti D, et al. Persistent B19 infection in immunocompetent individuals: implications for transfusion safety. Blood 2005; 106:2890-5.
38. Lindblom A, Isa A, Norbeck O, et al. Slow clearance of human parvovirus B19 viremia following acute infection. Clin Infect Dis 2005; 41:1201-3.
39. Yaegashi N, Niinuma T, Chisaka H, et al. The incidence of, and factors leading to, parvovirus B19-related hydrops fetalis following maternal infection: report of 10 cases and meta-analysis. J Infect 1998; 37:28-35.
40. Söderlund M, Ruutu P, Ruutu T, Asikainen K, Franssila R, Hedman K. Primary and secondary infections by human parvovirus B19 following bone marrow transplantation: characterization by PCR and B-cell molecular immunology. Scand J Infect Dis 1997; 29:129-35.